Избранные публикации за 5 лет

1. Wadkin LE, Orozco-Fuentes S, Neganova I, Bojic S, Laude A, Lako M, Parker NG, Shukurov A, 2019. Seeding hESCs to achieve optimal colony clonality. Scientific Reports. 2019, 9 :15299; doi. 10.1038/s41598-019–51897‑0.

2. Orozco-Fuentes S, Neganova I, Wadkin LE, Baggaley AW, Barrio RA, Lako M, Shukurov A, Parker NG. Quantification of the morphological characteristics of hESC colonies for the best colony assessment. Scientific Reports, 2019, 9:17569; doi.10.1038/s41598-019–53719‑9.

3. Tentler D, Lomert E, Novitskaya K, Barlev NA. Role of ACTN4 in Tumorigenesis, Metastasis, and EMT. Cells. 2019, Nov 13;8(11). pii: E1427. doi: 10.3390/cells8111427.

4. Gagliardi M, Cotella D, Santoro C, Corà D, Barlev NA, Piacentini M, Corazzari M. Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. Cell Death Dis. 2019, Nov 28;10(12):902. doi: 10.1038/s41419-019‑2143‑7.

5. Villella VR, Esposito S, Ferrari E, Monzani R, Tosco A, Rossin F, Castaldo A, Silano M, Marseglia GL, Romani L, Barlev NA, Piacentini M, Raia V, Kroemer G, Maiuri L. Autophagy suppresses the pathogenic immune response to dietary antigens in cystic fibrosis. Cell Death Dis. 2019. Mar 15;10(4):258. doi: 10.1038/s41419-019‑1500‑x.

6. Loboda AP, Soond SM, Piacentini M, Barlev NA. Lysine-specific post-translational modifications of proteins in the life cycle of viruses. Cell Cycle. 2019, Sep;18(17):1995–2005. doi: 10.1080/15384101.2019.1639305.

7. Titov A, Petukhov A, Staliarova A, Motorin D, Bulatov E, Shuvalov O, Soond SM, Piacentini M, Melino G, Zaritskey A, Barlev NA. The biological basis and clinical symptoms of CAR‑T therapy-associated toxicites. Cell Death Dis. 2018 Sep 4;9(9):897. doi: 10.1038/s41419-018‑0918‑x.

8. Rossin F, Villella VR, D’Eletto M, Farrace MG, Esposito S, Ferrari E, Monzani R, Occhigrossi L, Pagliarini V, Sette C, Cozza G, Barlev NA, Falasca L, Fimia GM, Kroemer G, Raia V, Maiuri L, Piacentini M. TG2 regulates the heat-shock response by the post-translational modification of HSF1. EMBO Rep. 2018 Jul;19(7). pii: e45067. doi: 10.15252/embr.201745067.

9. Piacentini M, Baiocchini A, Del Nonno F, Melino G, Barlev NA, Rossin F, D’Eletto M, Falasca L. Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2. Cell Death Dis. 2018 Feb 15;9(3):257. doi: 10.1038/s41419-018‑0292‑8.

10. Borchsenius SN, Daks A, Fedorova O, Chernova O, Barlev NA. Effects of mycoplasma infection on the host organism response via p53/NF-κB signaling. J Cell Physiol. 2018 Jan;234(1):171–180. doi: 10.1002/jcp.26781.